<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Radiotherapy (RT) is one of the most effective tools in the clinical treatment of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Because the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor p53 plays a central role in radiation-mediated responses, including cell cycle-arrest and <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, a number of studies have suggested that p53 could be a useful therapeutic target of anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> agents </plain></SENT>
<SENT sid="2" pm="."><plain>Accordingly, we sought to discover a new agent capable of increasing p53 activity </plain></SENT>
<SENT sid="3" pm="."><plain>HCT116 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells, containing <z:mp ids='MP_0002169'>wild-type</z:mp> p53, were stably transfected with a p53 responsive-luciferase (p53-Luc) reporter gene </plain></SENT>
<SENT sid="4" pm="."><plain>A cell-based high-throughput screen of 7920 synthetic small molecules was performed in duplicate </plain></SENT>
<SENT sid="5" pm="."><plain>Of the screened compounds, acriflavine (ACF) significantly increased p53-Luc activity in a concentration-dependent manner without causing toxicity </plain></SENT>
<SENT sid="6" pm="."><plain>Pretreatment with ACF enhanced the induction of p53 protein expression and phosphorylation on serine 15 by γ-irradiation </plain></SENT>
<SENT sid="7" pm="."><plain>Clonogenic assays showed that ACF pretreatment also potentiated radiation-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The combination of irradiation and ACF treatment induced <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> release of <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> and significant activation of caspase-3 with PARP cleavage in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells, demonstrating typical apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Combined treatment with ACF and radiation increased the expression of Bax and Bad, while decreasing expression of Bcl-2 </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, the ACF/radiation treatment combination induced endoplasmic reticulum (ER) stress responses mediated by IRE1α (<z:chebi fb="1" ids="24848">inositol</z:chebi>-requiring transmembrane kinase and endonuclease 1α), eIF-2α (eukaryotic initiation factor 2α), caspase-2/12, and CHOP (C/EBP homologous protein) </plain></SENT>
<SENT sid="11" pm="."><plain>The knockdown of IRE1α by siRNA inhibited the apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> induced by ACF/radiation treatment </plain></SENT>
<SENT sid="12" pm="."><plain>In vivo studies showed that combined treatment with ACF and radiation significantly inhibited the growth of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> xenografted mice </plain></SENT>
<SENT sid="13" pm="."><plain>These results indicate that ACF acts through p53-dependent <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> pathways and ER stress signals, and could be a promising radiosensitizer </plain></SENT>
</text></document>